The Way to Profit From the Biotech Story No One Is Talking About By: TalkMarkets September 16, 2016 at 16:24 PM EDT By the standard of today’s mega-mergers, a $4 million investment seems like pretty small change. Read More >> Related Stocks: AbbVie Abbott Laboratories Biotechnology Index NYSE ETF Celgene Corp Danaher Corp Editas Medicine Johnson & Johnson Lexicon Pharmaceutcl Merck & Co Nektar Therapeutics Pfizer Reata Pharma Regeneron Pharmaceuticals Sanofi-Aventis S.A. ADR Seagen Inc